^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
DiviTum® TKa test

Company:
Biovica
Type:
Laboratory Developed Test

Details

Evidence
DiviTum® TKa is a blood-based biomarker test that monitors and predicts treatment response in hormone receptor-positive metastatic breast cancer. The test measures thymidine kinase activity (TKa) which reflects cell proliferation.
Cancer:
Hormone Receptor Positive Breast Cancer
Gene:
ER (Estrogen receptor), PGR (Progesterone receptor)
Method:
Blood-based biomarker test